Trailing-twelve-month (TTM) revenue is $1.35 Billion with a year-over-year growth of (13.23%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q1 FY2026Period ended 2025-09-30 | $367,883,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q2 FY2026Period ended 2025-12-31 | $384,120,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-09 |
| Q3 FY2026Period ended 2026-03-31 | $338,357,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-11 |
| Q4 FY2026Period ended 2026-06-30 | $263,069,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-09-14 |
| TTM revenue | $1,353,429,000 |
Current P/S: $47,825,330 market capitalization ÷ $1,353,429,000 TTM revenue = 0.04x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T16:39:42.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q4 FY2026 (2026-06-30): $263.07M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T16:42:33.125Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-06-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-06-30 · USD | FY20222022-06-30 · USD | FY20232023-06-30 · USD | FY20242024-06-30 · USD | FY20252025-06-30 · USD | FY20262026-06-30 · USD |
|---|---|---|---|---|---|---|
| Baby/Kids | N/A | N/A | $285M | $252M | $242M | $215M |
| Grocery | $1.3B | $736M | $239M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-06-30 · USD | FY20222022-06-30 · USD | FY20232023-06-30 · USD | FY20242024-06-30 · USD | FY20252025-06-30 · USD | FY20262026-06-30 · USD |
|---|---|---|---|---|---|---|
| All Other Locations | $408M | $354M | $113M | N/A | N/A | N/A |
| CANADA | N/A | N/A |
$1.35B
$1.35 Billion
(13.23%)
vs. $1.56B a year ago (TTM)
(7.24%)
5 Year compound annual growth rate
1 Year
(13.23%)
3 Year
(9.01%)
5 Year
(7.24%)
10 Year
(7.16%)
15 Year
+1.21%
20 Year
+3.07%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $1.35B | ($206.35M) | (13.23%) |
| 2025 | $1.56B | ($176.51M) | (10.17%) |
| 2024 | $1.74B | ($60.36M) | (3.36%) |
| 2023 | $1.80B | ($95.15M) | (5.03%) |
| 2022 | $1.89B | ($78.51M) | (3.98%) |
| 2021 |
TTM Growth
(13.23%)
3-Year CAGR
(9.01%)
5-Year CAGR
(7.24%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T16:42:33.125Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-06-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $245M |
| $256M |
| Meal Preparation | N/A | N/A | $653M | $662M | $640M | $620M |
|---|
| Personal Care | $186M | $98M | $133M | $105M | $63M | $49M |
|---|
| Snacks | $322M | $662M | $486M | $463M | $371M | $213M |
|---|
| Tea | $137M | $396M | N/A | N/A | N/A | N/A |
|---|
| $115M |
| $111M |
| $74M |
| Europe | N/A | N/A | $180M | N/A | N/A | N/A |
|---|
| UNITED STATES | $954M | $1.0B | $1.0B | $940M | $778M | $611M |
|---|
| Western Europe | N/A | N/A | N/A | $184M | $179M | $188M |
|---|
| $1.97B |
| ($83.60M) |
| (4.07%) |
| 2020 | $2.05B | ($50.70M) | (2.41%) |
| 2019 | $2.10B | ($161.06M) | (7.11%) |
| 2018 | $2.27B | ($77.83M) | (3.32%) |
| 2017 | $2.34B | ($49.36M) | (2.06%) |
